SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Alzheimer's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-alzheimers-disease
Related Entities
diseases-alzheimers-disease
Metadata
slugdiseases-alzheimers-disease
entity_typedisease
kg_node_idNone
Linked Artifacts (1763)
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy80%
related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease80%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia80%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation80%
related🧪Complement C1QA Spatial Gradient in Cortical Layers80%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation80%
related🧪APOE Isoform Expression Across Glial Subtypes80%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro80%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli80%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK80%
see_also📖Alzheimer's Disease Biomarkers80%
see_also📖ASL Perfusion Biomarkers for Alzheimer's Disease80%
see_also📖Digital Biomarkers for Alzheimer's Disease80%
see_also📖Dried Blood Spot Biomarker Test for Alzheimer's Disease80%
see_also📖DTI Biomarkers for Alzheimer's Disease80%
see_also📖EEG Biomarkers for Alzheimer's Disease80%
see_also📖Eye-Tracking Digital Markers in Alzheimer's Disease80%
see_also📖Gait Biomarkers for Alzheimer's Disease80%
see_also📖GFAP in Alzheimer's Disease80%
see_also📖Inflammatory Biomarkers in Alzheimer's Disease80%
see_also📖Neurogranin - Alzheimer's Disease Biomarker80%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease80%
see_also📖Ocular Fluid Biomarkers for Alzheimer's Disease80%
see_also📖Olfactory Biomarkers for Alzheimer's Disease80%
see_also📖Plasma Phospho-Tau Ratio Diagnostic Panel for Alzheimer'80%
see_also📖Salivary Biomarkers for Alzheimer's Disease80%
see_also📖Sleep Biomarkers for Alzheimer's Disease80%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease80%
see_also📖Synaptic Biomarkers for Alzheimer's Disease80%
see_also📖Tear Film Biomarkers in Alzheimer's Disease80%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers80%
see_also📖Diffuse Amyloid Deposits in Alzheimer's Disease80%
see_also📖ACP-204 for Alzheimer's Disease Psychosis (NCT06159673)80%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh80%
see_also📖ASN90 Phase 2 Trial - Early Alzheimer's Disease (NCT05680%
see_also📖BIIB080 (MAPTRx) Antisense Oligonucleotide for Alzheimer80%
see_also📖BMS-986368 Phase 2 - Agitation in Alzheimer's Disease80%
see_also📖BMS-986446 Phase 2 Trial for Early Alzheimer's Disease80%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058280%
see_also📖Centella asiatica Phase 1 Trial for Alzheimer's Disease80%
see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06780%
see_also📖Escitalopram for Agitation in Alzheimer's Disease (NCT080%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer80%
see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di80%
see_also📖Fasudil for Early Alzheimer's Disease (FEAD) - NCT0636280%
see_also📖[F-18]Flornaptitril PET - Phase 3 for Alzheimer's Disea80%
see_also📖Foralumab Phase 2 Trial for Alzheimer's Disease80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖Guanfacine NorAD - Phase 3 Trial for Alzheimer's Diseas80%
see_also📖IGC-AD1 for Agitation in Alzheimer's Disease (NCT05543680%
see_also📖ITI-1284 for Alzheimer's Disease Psychosis (NCT0654083380%
see_also📖KarXT (Xanomeline/Trospium) - Phase 3 for Alzheimer's D80%
see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise80%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 80%
see_also📖NCT03875638 - Levetiracetam for Alzheimer's Disease80%
see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime80%
see_also📖LHP588: P. gingivalis Targeting for Alzheimer's Disease80%
see_also📖MAR Polypill for Alzheimer's Disease (NCT06597058)80%
see_also📖Masupirdine for Alzheimer's Disease Agitation80%
see_also📖Masupirdine for Agitation in Alzheimer's Disease (NCT0580%
see_also📖MK-2214 for Early Alzheimer's Disease80%
see_also📖Nabilone for Agitation in Alzheimer's Disease (NCT0451680%
see_also📖NAB-IT: Nabilone for Agitation in Alzheimer's Disease80%
see_also📖TRAILBLAZER-ALZ 3 (NCT05026866) — Donanemab for Preclinical 80%
see_also📖GV1001 for Moderate to Severe Alzheimer's Disease (NCT080%
see_also📖Biogen Alzheimer's Disease Phase 2 Trial (NCT05399888)80%
see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di80%
see_also📖CBD (Cannabidiol) for Alzheimer's Disease Agitation - N80%
see_also📖GSK4527226 (AL101) for Early Alzheimer's Disease (NCT0680%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC80%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI80%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St80%
see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451680%
see_also📖Master Screening Study to Determine Individuals With Potenti80%
see_also📖NRTIs for Alzheimer's Disease - Phase 1 (NCT07210528)80%
see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer80%
see_also📖DMB-I (Latrepirdine) Phase 3 (NCT07251023) — Alzheimer'80%
see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial80%
see_also📖NCT06582706: Nicotinic Acid for Alzheimer's Disease80%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A80%
see_also📖NRTIs for Alzheimer's Disease: Targeting Type-I Interfe80%
see_also📖ONO-2020 for Alzheimer's Disease (NCT06881836)80%
see_also📖NCT06803823 - ONO-2020 for Agitation in Alzheimer's Dis80%
see_also📖Ozanimod for Alzheimer's Disease (NCT06862960)80%
see_also📖Piromelatine 20 mg for Mild Dementia Due to Alzheimer's80%
see_also📖PLX5622 CSF1R Inhibitor Trial in Early Alzheimer's Dise80%
see_also📖Probiotics in Mild Alzheimer's Disease (NCT06181513)80%
see_also📖Recombinant Human Serum Albumin for Alzheimer's Disease80%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime80%
see_also📖Senicapoc Alzheimer's Disease Trial - NCT0480424180%
see_also📖SHR-1707 for Alzheimer's Disease (NCT06199037)80%
see_also📖Siponimod for Alzheimer's Disease (NCT06639282)80%
see_also📖SNIFF-Combo: Intranasal Insulin + Empagliflozin for Alzheime80%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention80%
see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'80%
see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial80%
see_also📖Alzheimer's Disease Mechanism Index80%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease80%
see_also📖APOE4 and Alzheimer's Disease Risk80%
see_also📖CD33 Siglec Receptor Dysfunction Alzheimer's Disease Ca80%
see_also📖Cholinergic System Degeneration in Alzheimer's Disease80%
see_also📖EEG Microstates in Alzheimer's Disease80%
see_also📖Endolysosomal Pathway in Alzheimer's Disease80%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t80%
see_also📖Glymphatic System in Alzheimer's Disease80%
see_also📖Locus Coeruleus Degeneration in Alzheimer's Disease80%
see_also📖Metal Ion Homeostasis in Alzheimer's Disease80%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa80%
see_also📖Neuroinflammation in Alzheimer's Disease80%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease80%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ80%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease80%
see_also📖Sex-Specific Mechanisms in Alzheimer's Disease80%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease80%
see_also📖Sporadic Alzheimer's Disease Pathway80%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway80%
see_also📖Tau Kinase-Phosphatase Balance in Alzheimer's Disease80%
see_also📖Tau Kinase Signaling Cascade in Alzheimer's Disease80%
see_also📖Ubiquitin-Proteasome System Dysfunction in Alzheimer's 80%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's80%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 80%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna79%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne78%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy72%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna71%
related🧪Prefrontal sensory gating circuit restoration via PV interne71%
mentions🧪Aquaporin-4 Polarization Rescue70%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%
related🧫Proposed experiment from debate on Synaptic pruning by micro70%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD70%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Anti-Tau Immunotherapy Dosing Optimization70%
related🧫ApoE4 Function in Alzheimer's Disease70%
related🧫Experiment: Autoimmune Hypothesis Testing in AD70%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#70%
related🧫Blood-Based Biomarker Panel for Early AD Detection70%
related🧫tACS Connectivity Trial in Early Alzheimer's70%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD70%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 70%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M70%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera70%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise70%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise70%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech70%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis70%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease70%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
related🧫Prion Strain Diversity and Selective Vulnerability70%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease70%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#70%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an70%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Tau ASO Therapy70%
related🧫Microglial TREM2 Agonist In Vivo Efficacy70%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol70%
related🧫Viral Infections and Alzheimer's Disease — causal mecha70%
related🧪HSP90-Tau Disaggregation Complex Enhancement70%
related🧪VCP-Mediated Autophagy Enhancement70%
related🧪LRP1-Dependent Tau Uptake Disruption70%
related🧪Extracellular Vesicle Biogenesis Modulation70%
related🧪Synaptic Vesicle Tau Capture Inhibition70%
related🧪TREM2-mediated microglial tau clearance enhancement70%
related🧪Trans-Synaptic Adhesion Molecule Modulation70%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro70%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli70%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK70%
related🧪Prefrontal sensory gating circuit restoration via PV interne70%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna70%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination65%
mentions🧪Netrin-1 Gradient Restoration65%
mentions🧪Oligodendrocyte White Matter Vulnerability65%
mentions🧪Purinergic Signaling Polarization Control65%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio65%
mentions🧪Mitochondrial-Lysosomal Contact Site Engineering65%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 65%
mentions🧪Circadian-Synchronized Proteostasis Enhancement65%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration65%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement65%
mentions🧪HSP90-Tau Disaggregation Complex Enhancement65%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer65%
mentions🧪Ganglioside Rebalancing Therapy65%
mentions🧪Mitochondrial SPM Synthesis Platform Engineering65%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon65%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective65%
mentions🧪Senescent Cell Mitochondrial DNA Release65%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption65%
mentions🧪Mitochondrial RNA Granule Rescue Pathway65%
mentions🧪Multi-Modal Stress Response Harmonization65%
mentions🧪Complement C1q Mimetic Decoy Therapy65%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu65%
mentions🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted65%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc65%
mentions🧪CYP46A1 Overexpression Gene Therapy65%
mentions🧪Liquid-Liquid Phase Separation Modifier Therapy65%
mentions🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor65%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade65%
mentions🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu65%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m65%
mentions🧪Retinal Vascular Microcirculation Rescue65%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition65%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho65%
mentions🧪Targeted Butyrate Supplementation for Microglial Phenotype M65%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation65%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi65%
mentions🧪Noradrenergic-Tau Propagation Blockade65%
mentions🧪Adenosine-Astrocyte Metabolic Reset65%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho65%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones65%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors65%
mentions🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists65%
mentions🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy65%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations65%
mentions🧪Quantum Coherence Disruption in Cellular Communication65%
mentions🧪The Glial Ketone Metabolic Shunt Hypothesis65%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation65%
mentions🧪LRP1-Dependent Tau Uptake Disruption65%
mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics65%
mentions🧪APOE-Dependent Autophagy Restoration65%
mentions🧪Glycosaminoglycan Template Disruption Approach65%
mentions🧪Extracellular Vesicle Biogenesis Modulation65%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes65%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem65%
mentions🧪SASP-Mediated Complement Cascade Amplification65%
mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization65%
mentions🧪Complement C1q Subtype Switching65%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting65%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification65%
mentions🧪Autophagosome Maturation Checkpoint Control65%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener65%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal65%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement65%
mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub65%
mentions🧪PARP1 Inhibition Therapy65%
mentions🧪Low Complexity Domain Cross-Linking Inhibition65%
mentions🧪Ocular Immune Privilege Extension65%
mentions🧪Hypocretin-Neurogenesis Coupling Therapy65%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation65%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu65%
mentions🧪Extracellular Matrix Stiffness Modulation65%
mentions🧪Synaptic Vesicle Tau Capture Inhibition65%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism65%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding65%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset65%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading65%
mentions🧪Piezoelectric Nanochannel BBB Disruption65%
mentions🧪Circadian-Synchronized LRP1 Pathway Activation65%
mentions🧪Glycine-Rich Domain Competitive Inhibition65%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation65%
mentions🧪Axonal RNA Transport Reconstitution65%
mentions🧪Optogenetic Control of Mitochondrial Transfer Networks65%
mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci65%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In65%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification65%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming65%
mentions🧪Orexin-Microglia Modulation Therapy65%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation65%
mentions🧪Lysosomal Membrane Repair Enhancement65%
mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement65%
mentions🧪Lysosomal Calcium Channel Modulation Therapy65%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro65%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue65%
mentions🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy65%
mentions🧪Blood-Brain Barrier SPM Shuttle System65%
mentions🧪Mitochondrial Transfer Pathway Enhancement65%
mentions🧪Stress Granule Phase Separation Modulators65%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr65%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction65%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation65%
mentions🧪Gap Junction Hemichannel Modulation for Controlled Mitochond65%
mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR65%
mentions🧪Membrane Cholesterol Gradient Modulators65%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto65%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu65%
mentions🧪Flotillin-1 Stabilization Compounds65%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization65%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy65%
mentions🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A65%
mentions🧪Complement-Mediated Synaptic Pruning Dysregulation65%
mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration65%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling65%
mentions🧪HDAC3-Selective Inhibition for Clock Reset65%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering65%
mentions🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati65%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th65%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation65%
mentions🧪Transcriptional Autophagy-Lysosome Coupling65%
mentions🧪Digital Twin-Guided Metabolic Reprogramming65%
mentions🧪TREM2-mediated microglial tau clearance enhancement65%
mentions🧪Lysosomal Positioning Dynamics Modulation65%
mentions🧪Lysosomal Enzyme Trafficking Correction65%
mentions🧪Circadian Clock-Autophagy Synchronization65%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri65%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai65%
mentions🧪Senescence-Associated Myelin Lipid Remodeling65%
mentions🧪Glial Glycocalyx Remodeling Therapy65%
mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor65%
mentions🧪Senescence-Activated NAD+ Depletion Rescue65%
mentions🧪Competitive APOE4 Domain Stabilization Peptides65%
mentions🧪Epigenetic Memory Erasure via TET2 Activation65%
mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol65%
mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy65%
mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy65%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy65%
mentions🧪Microglia-Derived Extracellular Vesicle Engineering for Targ65%
mentions🧪Mechanosensitive Ion Channel Reprogramming65%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation65%
mentions🧪Selective Acid Sphingomyelinase Modulation Therapy65%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)65%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme65%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon65%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors65%
mentions🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction65%
mentions🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling65%
mentions🧪Microbial Inflammasome Priming Prevention65%
mentions🧪Phase-Separated Organelle Targeting65%
mentions🧪Nucleolar Stress Response Normalization65%
mentions🧪Vagal Afferent Microbial Signal Modulation65%
mentions🧪Cross-Seeding Prevention Strategy65%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam65%
mentions🧪Purinergic P2Y12 Inverse Agonist Therapy65%
mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection65%
mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat65%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch65%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming65%
mentions🧪Trans-Synaptic Adhesion Molecule Modulation65%
mentions🧪Sphingomyelin Synthase Activators for Raft Remodeling65%
mentions🧪RNA Granule Nucleation Site Modulation65%
mentions🧪Sphingolipid Metabolism Reprogramming65%
related🧪VCP-Mediated Autophagy Enhancement63%
mentions🧫Endothelial CD2AP knockdown effects on memory in male mice60%
mentions🧫SPP1-mediated microglial synaptic engulfment assay60%
mentions🧫CD2AP expression and cognitive decline in AD patients60%
mentions🧫Competing endogenous RNA (ceRNA) network construction60%
mentions🧫Neuroimmune modulation and Aβ clearance mechanisms60%
mentions🧫GWAS of plasma NfL in East Asian cohort60%
mentions🧫Bioinformatics analysis and hub gene identification60%
mentions🧫Network Pharmacology Analysis of Shared AD Targets60%
mentions🧫Cognitive impact of TDP-43 pathology in AD patients60%
mentions🧫Meta-analysis of LRP1 C766T polymorphism and Alzheimer'60%
mentions🧫GWAS of composite biomarker score60%
mentions🧫MRI Phenotyping Method Concordance in Serbian AD Cohort60%
mentions🧫HDAC4 inhibition and NHE6 expression mechanism study60%
mentions🧫Endothelin-1 receptor A antagonist rescue in male CD2AP mice60%
mentions🧫Endothelin-1 receptor A antagonist rescue experiment60%
mentions🧫Reelin treatment rescue via ApoER2 in CD2AP mutant mice60%
mentions🧫SPP1 upregulation in perivascular cells in AD mouse models60%
mentions🧫Amyloid plaque load analysis in triple-mutant mouse brains60%
mentions🧫Plasma ATN biomarkers across AD continuum in Chilean cohort60%
mentions🧫16S rRNA sequencing of gut microbiome in PH-PS treated mice60%
mentions🧫GWAS of plasma pTau217 in East Asian cohort60%
mentions🧫PH-PS treatment in 5×FAD Alzheimer's disease mice60%
mentions🧫SIRPα modulation in mouse models of Alzheimer's disease60%
mentions🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho60%
mentions🧫Spp1 knockout prevents synaptic loss in AD mouse models60%
mentions🧫Creation and validation of 3xAD-ChAT-Cre mouse model60%
mentions🧫In vivo BBB transport of LPS-carrying bEVs60%
mentions🧫Real-world safety study of Lecanemab in Japanese AD patients60%
mentions🧫CHI3L1 variant association with AD progression in human pati60%
mentions🧫Diosmin cognitive rescue in APP/PS1 mice60%
mentions🧫GWAS of plasma pTau181 in East Asian cohort60%
mentions🧫Tet2 modulation in Aβ42-injured mouse hippocampal neurons60%
mentions🧫Behavioral assessment of APP/PSEN1/GD3S triple-mutant mice60%
mentions🧫Immunofluorescence analysis of cerebral microvascular densit60%
mentions🧫Cell-cell interaction analysis of perivascular-microglial cr60%
mentions🧫SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice60%
mentions🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model60%
mentions🧫Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's d60%
mentions🧫CD2AP downregulation in brain endothelial cells - memory fun60%
mentions🧫Transcriptomic profiling and differential expression analysi60%
mentions🧫AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral stud60%
mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc60%
mentions🧫bEV-mediated synaptic pruning via C1q-C3 pathway60%
mentions🧫AhR agonist effects on NEP expression in N2a cells60%
mentions🧫AhR transcriptional regulation of NEP gene60%
mentions🧫GWAS of plasma GFAP in East Asian cohort60%
mentions🧫AhR agonist effects on NEP in APP/PS1 mice60%
mentions🧫Abeta-induced cell death and aggregation in GD3S-deficient n60%
mentions🧫bEV isolation and LPS quantification from human samples60%
mentions🧫Cerebral blood flow regulation in CD2AP mutant mice60%
mentions🧫Meta-analysis of physical activity interventions on cognitiv60%
mentions🧫Single-nucleus RNA-seq integration analysis60%
mentions🧫Generation of Aβ-specific Tregs using CRISPR-Cas960%
mentions🧫qPCR and western blot analysis of microvascular functional m60%
mentions🧫Reelin glycoprotein treatment rescue experiment60%
mentions🧫bEV extraction and analysis from mouse samples60%
mentions🧫KEEPS Continuation: Long-term effects of menopausal hormone 60%
mentions🧫Summary-based Mendelian randomization analysis60%
mentions🧫Anti-ASC antibody intracerebroventricular injection in APP/P60%
mentions🧫ASC antibody treatment in SH-SY5Y-APP695 cells60%
mentions🧫Tet2 expression analysis in aged 2×Tg-AD mouse brains60%
mentions🧫Morphological characterization of microglial states in human60%
mentions🧫Microglial SIRPα expression in human Alzheimer's diseas60%
mentions🧫APOE4 association with TDP-43 pathology in AD60%
mentions🧫Microglial activation by bEVs via Piezo160%
mentions🧫Curcumin-Licorice Combination in D-galactose/Sodium Nitrite 60%
mentions🧫Cerebrovascular function analysis in CD2AP mutant mice60%
mentions🧫CD2AP loss association with cognitive decline in AD patients60%
mentions🧫TDP-43 pathology prevalence and distribution in AD cases60%
mentions🧪Epigenetic Memory Reprogramming for Alzheimer's Disease60%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba60%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise60%
mentions🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 60%
mentions🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 60%
mentions🔬SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh60%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&60%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&60%
mentions🔬Neuroinflammation and microglial priming in early AD — Analy60%
mentions🔬Does SYK activation provide neuroprotection or exacerbate ne60%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas60%
mentions🔬SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh60%
mentions🔬Analysis question not specified60%
mentions🧫P2rx7 genetic deletion in PS19 tauopathy mice60%
mentions🧫Gene Replacement-Alzheimer's Disease (GR-AD) Mouse Mode60%
mentions🧫Plant-based dietary patterns and Alzheimer's disease ri60%
mentions🧫Epigenetic clocks association with brain aging patterns in o60%
mentions🧫ABCA1 rs2230806 polymorphism association with dementia risk 60%
mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi60%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro60%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece60%
mentions🧫s:** - Test MCU overexpression specifically in layer II neur60%
mentions🧫Proposed experiment from debate on Perivascular spaces and g60%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional60%
mentions🧫Proposed experiment from debate on Perivascular spaces and g60%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
mentions🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr60%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment60%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%
mentions🧫Experiment Index60%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M60%
mentions🧫Cytochrome Therapeutics60%
mentions🧫NPH Glymphatic System Interaction Experiment60%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
mentions🧫Prion Strain Diversity and Selective Vulnerability in CJD60%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec60%
mentions🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro60%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS60%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 60%
related🧫Endothelial CD2AP knockdown effects on memory in male mice60%
related🧫SPP1-mediated microglial synaptic engulfment assay60%
related🧫CD2AP expression and cognitive decline in AD patients60%
related🧫Competing endogenous RNA (ceRNA) network construction60%
related🧫Neuroimmune modulation and Aβ clearance mechanisms60%
related🧫GWAS of plasma NfL in East Asian cohort60%
related🧫Bioinformatics analysis and hub gene identification60%
related🧫Network Pharmacology Analysis of Shared AD Targets60%
related🧫Cognitive impact of TDP-43 pathology in AD patients60%
related🧫Meta-analysis of LRP1 C766T polymorphism and Alzheimer'60%
related🧫GWAS of composite biomarker score60%
related🧫MRI Phenotyping Method Concordance in Serbian AD Cohort60%
related🧫HDAC4 inhibition and NHE6 expression mechanism study60%
related🧫Endothelin-1 receptor A antagonist rescue in male CD2AP mice60%
related🧫Endothelin-1 receptor A antagonist rescue experiment60%
related🧫Reelin treatment rescue via ApoER2 in CD2AP mutant mice60%
related🧫SPP1 upregulation in perivascular cells in AD mouse models60%
related🧫Amyloid plaque load analysis in triple-mutant mouse brains60%
related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort60%
related🧫16S rRNA sequencing of gut microbiome in PH-PS treated mice60%
related🧫GWAS of plasma pTau217 in East Asian cohort60%
related🧫PH-PS treatment in 5×FAD Alzheimer's disease mice60%
related🧫SIRPα modulation in mouse models of Alzheimer's disease60%
related🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho60%
related🧫Spp1 knockout prevents synaptic loss in AD mouse models60%
related🧫Creation and validation of 3xAD-ChAT-Cre mouse model60%
related🧫In vivo BBB transport of LPS-carrying bEVs60%
related🧫Real-world safety study of Lecanemab in Japanese AD patients60%
related🧫CHI3L1 variant association with AD progression in human pati60%
related🧫Diosmin cognitive rescue in APP/PS1 mice60%
related🧫GWAS of plasma pTau181 in East Asian cohort60%
related🧫Tet2 modulation in Aβ42-injured mouse hippocampal neurons60%
related🧫Behavioral assessment of APP/PSEN1/GD3S triple-mutant mice60%
related🧫Immunofluorescence analysis of cerebral microvascular densit60%
related🧫Cell-cell interaction analysis of perivascular-microglial cr60%
related🧫SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice60%
related🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model60%
related🧫Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's d60%
related🧫CD2AP downregulation in brain endothelial cells - memory fun60%
related🧫Transcriptomic profiling and differential expression analysi60%
related🧫AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral stud60%
related🧫Single-cell RNA sequencing of microglial states in AD hippoc60%
related🧫bEV-mediated synaptic pruning via C1q-C3 pathway60%
related🧫AhR agonist effects on NEP expression in N2a cells60%
related🧫AhR transcriptional regulation of NEP gene60%
related🧫GWAS of plasma GFAP in East Asian cohort60%
related🧫AhR agonist effects on NEP in APP/PS1 mice60%
related🧫Abeta-induced cell death and aggregation in GD3S-deficient n60%
related🧫bEV isolation and LPS quantification from human samples60%
related🧫Cerebral blood flow regulation in CD2AP mutant mice60%
related🧫Meta-analysis of physical activity interventions on cognitiv60%
related🧫Single-nucleus RNA-seq integration analysis60%
related🧫Generation of Aβ-specific Tregs using CRISPR-Cas960%
related🧫qPCR and western blot analysis of microvascular functional m60%
related🧫Reelin glycoprotein treatment rescue experiment60%
related🧫bEV extraction and analysis from mouse samples60%
related🧫KEEPS Continuation: Long-term effects of menopausal hormone 60%
related🧫Summary-based Mendelian randomization analysis60%
related🧫Anti-ASC antibody intracerebroventricular injection in APP/P60%
related🧫ASC antibody treatment in SH-SY5Y-APP695 cells60%
related🧫Tet2 expression analysis in aged 2×Tg-AD mouse brains60%
related🧫Morphological characterization of microglial states in human60%
related🧫Microglial SIRPα expression in human Alzheimer's diseas60%
related🧫APOE4 association with TDP-43 pathology in AD60%
related🧫Microglial activation by bEVs via Piezo160%
related🧫Curcumin-Licorice Combination in D-galactose/Sodium Nitrite 60%
related🧫Cerebrovascular function analysis in CD2AP mutant mice60%
related🧫CD2AP loss association with cognitive decline in AD patients60%
related🧫TDP-43 pathology prevalence and distribution in AD cases60%
related🧫Gene Replacement-Alzheimer's Disease (GR-AD) Mouse Mode60%
related🧫Plant-based dietary patterns and Alzheimer's disease ri60%
related🧫Longitudinal dietary change analysis and ADRD risk over 10 y60%
related🧫P2rx7 genetic deletion in PS19 tauopathy mice60%
related🧫Cell type-specific P2rx7 deletion in microglia vs astrocytes60%
related🧫Brain-derived extracellular vesicles proteome analysis60%
related🧫BDEV injection and recipient microglial transcriptome analys60%
related🧫Single-cell RNA sequencing of mouse brains60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫TREM2 KO amyloid pathology study60%
related🧫ABCA1 rs2230806 polymorphism association with dementia risk 60%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination58%
related🧪Netrin-1 Gradient Restoration58%
related🧪Oligodendrocyte White Matter Vulnerability58%
related🧪Purinergic Signaling Polarization Control58%
related🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio58%
related🧪Mitochondrial-Lysosomal Contact Site Engineering58%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 58%
related🧪Circadian-Synchronized Proteostasis Enhancement58%
related🧪HSP90-Tau Disaggregation Complex Enhancement58%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer58%
related🧪Ganglioside Rebalancing Therapy58%
related🧪Mitochondrial SPM Synthesis Platform Engineering58%
related🧪CX43 hemichannel engineering enables size-selective mitochon58%
related🧪Senescent Cell Mitochondrial DNA Release58%
related🧪SASP-Mediated Cholinergic Synapse Disruption58%
related🧪Mitochondrial RNA Granule Rescue Pathway58%
related🧪Multi-Modal Stress Response Harmonization58%
related🧪Complement C1q Mimetic Decoy Therapy58%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu58%
related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted58%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc58%
related🧪CYP46A1 Overexpression Gene Therapy58%
related🧪Liquid-Liquid Phase Separation Modifier Therapy58%
related🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade58%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m58%
related🧪Retinal Vascular Microcirculation Rescue58%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition58%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho58%
related🧪Targeted Butyrate Supplementation for Microglial Phenotype M58%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation58%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi58%
related🧪Noradrenergic-Tau Propagation Blockade58%
related🧪Adenosine-Astrocyte Metabolic Reset58%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho58%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones58%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors58%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists58%
related🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy58%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations58%
related🧪Quantum Coherence Disruption in Cellular Communication58%
related🧪The Glial Ketone Metabolic Shunt Hypothesis58%
related🧪LRP1-Dependent Tau Uptake Disruption58%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics58%
related🧪APOE-Dependent Autophagy Restoration58%
related🧪Extracellular Vesicle Biogenesis Modulation58%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes58%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem58%
related🧪SASP-Mediated Complement Cascade Amplification58%
related🧪APOE-Mediated Synaptic Lipid Raft Stabilization58%
related🧪Complement C1q Subtype Switching58%
related🧪Heat Shock Protein 70 Disaggregase Amplification58%
related🧪Autophagosome Maturation Checkpoint Control58%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener58%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal58%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement58%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub58%
related🧪PARP1 Inhibition Therapy58%
related🧪Low Complexity Domain Cross-Linking Inhibition58%
related🧪Ocular Immune Privilege Extension58%
related🧪Hypocretin-Neurogenesis Coupling Therapy58%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation58%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu58%
related🧪Extracellular Matrix Stiffness Modulation58%
related🧪Synaptic Vesicle Tau Capture Inhibition58%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism58%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset58%
related🧪Senescence-Induced Lipid Peroxidation Spreading58%
related🧪Piezoelectric Nanochannel BBB Disruption58%
related🧪Circadian-Synchronized LRP1 Pathway Activation58%
related🧪Glycine-Rich Domain Competitive Inhibition58%
related🧪SASP-Driven Aquaporin-4 Dysregulation58%
related🧪Axonal RNA Transport Reconstitution58%
related🧪Optogenetic Control of Mitochondrial Transfer Networks58%
related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci58%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In58%
related🧪Circadian-Gated Maresin Biosynthesis Amplification58%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming58%
related🧪Orexin-Microglia Modulation Therapy58%
related🧪KDM6A-Mediated H3K27me3 Rejuvenation58%
related🧪Lysosomal Membrane Repair Enhancement58%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement58%
related🧪Lysosomal Calcium Channel Modulation Therapy58%
related🧪Blood-Brain Barrier SPM Shuttle System58%
related🧪Mitochondrial Transfer Pathway Enhancement58%
related🧪Stress Granule Phase Separation Modulators58%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr58%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction58%
related🧪Pharmacological Enhancement of APOE4 Glycosylation58%
related🧪Gap Junction Hemichannel Modulation for Controlled Mitochond58%
related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR58%
related🧪Membrane Cholesterol Gradient Modulators58%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto58%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu58%
related🧪Flotillin-1 Stabilization Compounds58%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization58%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy58%
related🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration58%
related🧪HDAC3-Selective Inhibition for Clock Reset58%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering58%
related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati58%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th58%
related🧪Transcriptional Autophagy-Lysosome Coupling58%
related🧪Digital Twin-Guided Metabolic Reprogramming58%
related🧪TREM2-mediated microglial tau clearance enhancement58%
related🧪Lysosomal Positioning Dynamics Modulation58%
related🧪Lysosomal Enzyme Trafficking Correction58%
related🧪Circadian Clock-Autophagy Synchronization58%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides58%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri58%
related🧪Senescence-Associated Myelin Lipid Remodeling58%
related🧪Glial Glycocalyx Remodeling Therapy58%
related🧪Senescence-Activated NAD+ Depletion Rescue58%
related🧪Competitive APOE4 Domain Stabilization Peptides58%
related🧪Epigenetic Memory Erasure via TET2 Activation58%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol58%
related🧪HCN1-Mediated Resonance Frequency Stabilization Therapy58%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy58%
related🧪Microglia-Derived Extracellular Vesicle Engineering for Targ58%
related🧪Mechanosensitive Ion Channel Reprogramming58%
related🧪Serine/Arginine-Rich Protein Kinase Modulation58%
related🧪Selective Acid Sphingomyelinase Modulation Therapy58%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)58%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme58%
related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon58%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors58%
related🧪Microbial Inflammasome Priming Prevention58%
related🧪Phase-Separated Organelle Targeting58%
related🧪Nucleolar Stress Response Normalization58%
related🧪Vagal Afferent Microbial Signal Modulation58%
related🧪Cross-Seeding Prevention Strategy58%
related🧪Purinergic P2Y12 Inverse Agonist Therapy58%
related🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection58%
related🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat58%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch58%
related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming58%
related🧪Trans-Synaptic Adhesion Molecule Modulation58%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling58%
related🧪RNA Granule Nucleation Site Modulation58%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I54%
related🧫Proposed experiment from debate on Synaptic pruning by micro54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫4R-Tau Targeting Therapies for PSP and CBS54%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi54%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau54%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti54%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?54%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap54%
related🧫Anti-Tau Immunotherapy Dosing Optimization54%
related🧫ApoE4 Function in Alzheimer's Disease54%
related🧫Experiment: Autoimmune Hypothesis Testing in AD54%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration54%
related🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#54%
related🧫Blood-Based Biomarker Panel for Early AD Detection54%
related🧫tACS Connectivity Trial in Early Alzheimer's54%
related🧫Brain Connectivity-Targeted tACS Trial in Early AD54%
related🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 54%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M54%
related🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera54%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera54%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa54%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation54%
related🧫Gap Junction Dysfunction Validation in Parkinson's Dise54%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas54%
related🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise54%
related🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech54%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr54%
related🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis54%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress54%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease54%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 54%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 54%
related🧫Prion Strain Diversity and Selective Vulnerability54%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease54%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#54%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and54%
related🧫Sleep Disruption and Alzheimer's Disease — mechanism an54%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation54%
related🧫Experiment Validation: In vitro ThT Assay54%
related🧫Tau ASO Therapy54%
related🧫Microglial TREM2 Agonist In Vivo Efficacy54%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia54%
related🧫Vascular Contribution to Alzheimer's Disease — Beyond A54%
related🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol54%
related🧫Viral Infections and Alzheimer's Disease — causal mecha54%
related🧫Longitudinal dietary change analysis and ADRD risk over 10 y54%
related🧫Cell type-specific P2rx7 deletion in microglia vs astrocytes54%
related🧫Brain-derived extracellular vesicles proteome analysis54%
related🧫BDEV injection and recipient microglial transcriptome analys54%
related🧫Single-cell RNA sequencing of mouse brains54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫TREM2 KO amyloid pathology study54%
related🧫Endothelial CD2AP knockdown effects on memory in male mice54%
related🧫SPP1-mediated microglial synaptic engulfment assay54%
related🧫CD2AP expression and cognitive decline in AD patients54%
related🧫Competing endogenous RNA (ceRNA) network construction54%
related🧫Neuroimmune modulation and Aβ clearance mechanisms54%
related🧫GWAS of plasma NfL in East Asian cohort54%
related🧫Bioinformatics analysis and hub gene identification54%
related🧫Network Pharmacology Analysis of Shared AD Targets54%
related🧫Cognitive impact of TDP-43 pathology in AD patients54%
related🧫Meta-analysis of LRP1 C766T polymorphism and Alzheimer'54%
related🧫GWAS of composite biomarker score54%
related🧫MRI Phenotyping Method Concordance in Serbian AD Cohort54%
related🧫HDAC4 inhibition and NHE6 expression mechanism study54%
related🧫Endothelin-1 receptor A antagonist rescue in male CD2AP mice54%
related🧫Endothelin-1 receptor A antagonist rescue experiment54%
related🧫Reelin treatment rescue via ApoER2 in CD2AP mutant mice54%
related🧫SPP1 upregulation in perivascular cells in AD mouse models54%
related🧫Amyloid plaque load analysis in triple-mutant mouse brains54%
related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort54%
related🧫16S rRNA sequencing of gut microbiome in PH-PS treated mice54%
related🧫GWAS of plasma pTau217 in East Asian cohort54%
related🧫PH-PS treatment in 5×FAD Alzheimer's disease mice54%
related🧫SIRPα modulation in mouse models of Alzheimer's disease54%
related🧫Dairy intake and dementia risk in Malmö Diet and Cancer coho54%
related🧫Spp1 knockout prevents synaptic loss in AD mouse models54%
related🧫Creation and validation of 3xAD-ChAT-Cre mouse model54%
related🧫In vivo BBB transport of LPS-carrying bEVs54%
related🧫Real-world safety study of Lecanemab in Japanese AD patients54%
related🧫CHI3L1 variant association with AD progression in human pati54%
related🧫Diosmin cognitive rescue in APP/PS1 mice54%
related🧫GWAS of plasma pTau181 in East Asian cohort54%
related🧫Tet2 modulation in Aβ42-injured mouse hippocampal neurons54%
related🧫Behavioral assessment of APP/PSEN1/GD3S triple-mutant mice54%
related🧫Immunofluorescence analysis of cerebral microvascular densit54%
related🧫Cell-cell interaction analysis of perivascular-microglial cr54%
related🧫SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice54%
related🧫Adoptive transfer of TCRAβ-Tregs in AD mouse model54%
related🧫Chi3l1 deletion in APP/PS1 mouse model of Alzheimer's d54%
related🧫CD2AP downregulation in brain endothelial cells - memory fun54%
related🧫Transcriptomic profiling and differential expression analysi54%
related🧫AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral stud54%
related🧫Single-cell RNA sequencing of microglial states in AD hippoc54%
related🧫bEV-mediated synaptic pruning via C1q-C3 pathway54%
related🧫AhR agonist effects on NEP expression in N2a cells54%
related🧫AhR transcriptional regulation of NEP gene54%
related🧫GWAS of plasma GFAP in East Asian cohort54%
related🧫AhR agonist effects on NEP in APP/PS1 mice54%
related🧫Abeta-induced cell death and aggregation in GD3S-deficient n54%
related🧫bEV isolation and LPS quantification from human samples54%
related🧫Cerebral blood flow regulation in CD2AP mutant mice54%
related🧫Meta-analysis of physical activity interventions on cognitiv54%
related🧫Single-nucleus RNA-seq integration analysis54%
related🧫Generation of Aβ-specific Tregs using CRISPR-Cas954%
related🧫qPCR and western blot analysis of microvascular functional m54%
related🧫Reelin glycoprotein treatment rescue experiment54%
related🧫bEV extraction and analysis from mouse samples54%
related🧫KEEPS Continuation: Long-term effects of menopausal hormone 54%
related🧫Summary-based Mendelian randomization analysis54%
related🧫Anti-ASC antibody intracerebroventricular injection in APP/P54%
related🧫ASC antibody treatment in SH-SY5Y-APP695 cells54%
related🧫Tet2 expression analysis in aged 2×Tg-AD mouse brains54%
related🧫Morphological characterization of microglial states in human54%
related🧫Microglial SIRPα expression in human Alzheimer's diseas54%
related🧫APOE4 association with TDP-43 pathology in AD54%
related🧫Microglial activation by bEVs via Piezo154%
related🧫Curcumin-Licorice Combination in D-galactose/Sodium Nitrite 54%
related🧫Cerebrovascular function analysis in CD2AP mutant mice54%
related🧫CD2AP loss association with cognitive decline in AD patients54%
related🧫TDP-43 pathology prevalence and distribution in AD cases54%
related🧪Epigenetic Memory Reprogramming for Alzheimer's Disease54%
related🔬What cell types are most vulnerable in Alzheimers Disease ba54%
related🔬What cell types are most vulnerable in Alzheimer's Dise54%
related🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 54%
related🔬Cell type vulnerability in Alzheimer's Disease (SEA-AD 54%
related🔬SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh54%
related🔬Neuroinflammation and microglial priming in early Alzheimer&54%
related🔬Neuroinflammation and microglial priming in early Alzheimer&54%
related🔬Neuroinflammation and microglial priming in early AD — Analy54%
related🔬Does SYK activation provide neuroprotection or exacerbate ne54%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas54%
related🔬SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh54%
related🔬Analysis question not specified54%
related🧫P2rx7 genetic deletion in PS19 tauopathy mice54%
related🧫Gene Replacement-Alzheimer's Disease (GR-AD) Mouse Mode54%
related🧫Plant-based dietary patterns and Alzheimer's disease ri54%
related🧫Epigenetic clocks association with brain aging patterns in o54%
related🧫ABCA1 rs2230806 polymorphism association with dementia risk 54%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi54%
related🧫Proposed experiment from debate on Synaptic pruning by micro54%
related🧫s:** - Temporal analysis showing mitochondrial defects prece54%
related🧫s:** - Test MCU overexpression specifically in layer II neur54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional54%
related🧫Proposed experiment from debate on Perivascular spaces and g54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr54%
related🧫DLB Cognitive Fluctuation Mechanism Experiment54%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P54%
related🧫Experiment Index54%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M54%
related🧫Cytochrome Therapeutics54%
related🧫NPH Glymphatic System Interaction Experiment54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Prion Strain Diversity and Selective Vulnerability in CJD54%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec54%
related🧫Tau Propagation Causality Test — Does Tau Spread Drive Neuro54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 54%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%
mentions🧪TREM2-Dependent Microglial Senescence Transition50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🧪Sphingomyelin Synthase Activators for Raft Remodeling50%
related🔬What gene expression changes in the aging mouse brain predic50%
see_also📖SLC16A1 — Solute Carrier Family 16 Member 1 (Monocarboxylate50%
see_also📖C1QA Gene50%
see_also📖slc17a7 Gene50%
see_also📖Agitation in Alzheimer's Disease50%
see_also📖Alzheimer's Disease Genetic Variants50%
see_also📖Alzheimer's Disease vs Parkinson's Disease Compari50%
see_also📖APP Mutations in Alzheimer's Disease50%
see_also📖DLB, Parkinson's Disease, and Alzheimer's Disease:50%
see_also📖Early-Onset Alzheimer's Disease (EOAD)50%
see_also📖Investment Landscape: Alzheimer's Disease50%
see_also📖Preclinical Alzheimer's Disease50%
see_also📖Prodromal Alzheimer's Disease50%
see_also📖PSEN1 Mutations in Alzheimer's Disease50%
see_also📖PSEN2 Mutations in Alzheimer's Disease50%
see_also📖Sporadic vs Familial Alzheimer's Disease: Comprehensive50%
see_also📖TREM2 Variants in Alzheimer's Disease50%
see_also📖CHMP4B — Charged Multivesicular Body Protein 4B50%
see_also📖SST Gene50%
see_also📖HSP90AA1 Gene50%
see_also📖PVALB Gene - Parvalbumin50%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Endosomal Sorting Defects in Neurodegeneration45%
see_also📖Neural Circuit Disruption in Neurodegeneration45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
mentions🧫Multi-omics analysis of myricanol effects on gene expression44%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model44%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise44%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I40%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro40%
mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD40%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 40%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS40%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi40%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau40%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti40%
mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?40%
mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap40%
mentions🧫Anti-Tau Immunotherapy Dosing Optimization40%
mentions🧫ApoE4 Function in Alzheimer's Disease40%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD40%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration40%
mentions🧫Biomarker-Guided Sequential Therapy Selection in Alzheimer&#40%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection40%
mentions🧫tACS Connectivity Trial in Early Alzheimer's40%
mentions🧫Brain Connectivity-Targeted tACS Trial in Early AD40%
mentions🧫Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 40%
mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M40%
mentions🧫Cholinergic System Dysfunction in DLB — Mechanisms and Thera40%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera40%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa40%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation40%
mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise40%
mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas40%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise40%
mentions🧫Microbiome-Gut-Brain Axis in Alzheimer's Disease — mech40%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr40%
mentions🧫Migraine Cortical Hyperexcitability and Alzheimer's Dis40%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress40%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease40%
mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 40%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 40%
mentions🧫Prion Strain Diversity and Selective Vulnerability40%
mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease40%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#40%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and40%
mentions🧫Sleep Disruption and Alzheimer's Disease — mechanism an40%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation40%
mentions🧫Experiment Validation: In vitro ThT Assay40%
mentions🧫Tau ASO Therapy40%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy40%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia40%
mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A40%
mentions🧫Vascular Contributions to Alzheimer Disease and Mixed Pathol40%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha40%
mentions📖AAIC 2025 Conference40%
mentions📖AAIC 2026 Company Presentations40%
mentions📖AAIC 2026 ISTAART Sessions40%
mentions📖AAIC 2026 Plenary Sessions40%
mentions📖AAIC 2026: Tau Immunotherapy40%
mentions📖AAN 2026 Clinical Trials40%
mentions📖AAN 2026 Plenary Sessions40%
mentions📖AAN 2026 — American Academy of Neurology Annual Meeting40%
mentions📖AAN 2026 — Amyotrophic Lateral Sclerosis40%
mentions📖AAN 2026 — Dementia40%
mentions📖AB Science40%
mentions📖AD JAK-STAT Inhibitor Companies40%
mentions📖AD Pipeline40%
mentions📖AD/PD 2025 Conference40%
mentions📖AD/PD 2026 Clinical Trial Updates40%
mentions📖AD/PD 2026 Company Presentations40%
mentions📖AD/PD 2026 Conference40%
mentions📖AD/PD 2026 Scientific Sessions40%
mentions📖ARCH Venture Partners40%
mentions📖Aarhus University40%
mentions📖Abbott Laboratories — Neurology40%
mentions📖Acadia Pharmaceuticals40%
mentions📖Accerise Inc.40%
mentions📖Aché Laboratórios40%
mentions📖Actinogen Medical40%
mentions📖Acumen Pharmaceuticals40%
mentions📖Acumen Pharmaceuticals, Inc.40%
mentions📖Ada Health40%
mentions📖Adam L. Boxer40%
mentions📖Adam S. Fleisher40%
mentions📖Adrian R. Urwyler40%
mentions📖Adriano Aguzzi40%
mentions📖Akili Interactive40%
mentions📖Alexei A. Kiselev40%
mentions📖Alison M. Goate40%
mentions📖Alnylam Pharmaceuticals40%
mentions📖Alos Biosciences40%
mentions📖AlzeCure Pharma AB40%
mentions📖Alzheon40%
mentions📖Alzinova AB40%
mentions📖Amgen40%
mentions📖Amolyt Pharma40%
mentions📖Amsterdam UMC (VUmc)40%
mentions📖Amylyx Pharmaceuticals, Inc.40%
mentions📖Anavex Life Sciences40%
mentions📖Annovis Bio40%
mentions📖Annovis Bio, Inc.40%
mentions📖Araclon Biotech S.L.40%
mentions📖Araim Pharmaceuticals40%
mentions📖Arbor Biotechnologies40%
mentions📖Arcus Biosciences40%
mentions📖AriBio40%
mentions📖Arnold B. Mitnitski40%
mentions📖Arrowhead Pharmaceuticals40%
mentions📖Asceneuron SA — OGA Inhibitor Biotech40%
mentions📖Asceneuron SA40%
mentions📖Astellas Pharma Inc.40%
mentions📖AstraZeneca plc40%
mentions📖Athira Pharma, Inc.40%
mentions📖AtlasX Bio40%
mentions📖Aurobindo Pharma Ltd.40%
mentions📖Autotac Bio Inc.40%
mentions📖BCI Companies40%
mentions📖Bagó40%
mentions📖Bart De Strooper40%
mentions📖Basilea Pharmaceutica AG40%
mentions📖Bayer AG40%
mentions📖Baylor College of Medicine40%
mentions📖Bengt Winblad40%
mentions📖Bial Pharmaceutical40%
mentions📖Bin Zhang40%
mentions📖BioArctic AB40%
mentions📖BioNTech SE40%
mentions📖BioSensics40%
mentions📖Biohaven40%
mentions📖Biolab Sanus40%
mentions📖Birgit Beach40%
mentions📖Bitbrain40%
mentions📖Blackrock Neurotech40%
mentions📖Blackrock Neurotech40%
mentions📖Boston University40%
mentions📖Bradley D. Carlson40%
mentions📖Bradley F. Boeve40%
mentions📖Bradley J. Wise40%
mentions📖BrainCo40%
mentions📖Brainomix40%
mentions📖Bristol Myers Squibb40%
mentions📖Bristol-Myers Squibb40%
mentions📖Bruce L. Miller40%
mentions📖Bruce Yankner40%
mentions📖Bukwang Pharmaceutical40%
mentions📖C. Dirk Keene40%
mentions📖CIEN Foundation40%
mentions📖CJ Healthcare40%
mentions📖CTAD 2025 Conference40%
mentions📖CTAD Conference40%
mentions📖CTRL-Labs40%
mentions📖Capital Medical University Beijing40%
mentions📖CarThera40%
mentions📖Carlo Ferraro — Movement Disorder Researcher40%
mentions📖Case Western Reserve University40%
mentions📖Case Western Reserve University40%
mentions📖Cassava Sciences, Inc.40%
mentions📖Catalent Pharma Solutions40%
mentions📖Cedars-Sinai Medical Center40%
mentions📖Cegedim40%
mentions📖Cellino Biotech, Inc.40%
mentions📖Cerebras Systems40%
mentions📖Cerecin40%
mentions📖Ceribell40%
mentions📖Cerêve40%
mentions📖Charco Neurotech40%
mentions📖Charité – Universitätsmedizin Berlin40%
mentions📖Cheng Song40%
mentions📖Cheng Xie40%
mentions📖Cheng Y. Gan40%
mentions📖Chiesi Farmaceutici S.p.A.40%
mentions📖Chinese Academy of Sciences40%
mentions📖Chugai Pharmaceutical Co., Ltd.40%
mentions📖Cipla Ltd.40%
mentions📖City University of New York (CUNY)40%
mentions📖ClearSky Medical Diagnostics40%
mentions📖Clifford R. Jack40%
mentions📖Clinical Utility of Integrated Biomarker Panels40%
mentions📖Cognicann40%
mentions📖Cognixion40%
mentions📖Cogstate40%
mentions📖Columbia University40%
mentions📖Companies Dashboard40%
mentions📖Company Rankings40%
mentions📖Conference Index40%
mentions📖Cornell University40%
mentions📖Cryopraxis40%
mentions📖Cyclica Inc40%
mentions📖Cyclica40%
mentions📖Cytokinetics, Inc.40%
mentions📖DIAXA Group40%
mentions📖Daewoong Pharmaceutical40%
mentions📖Daiichi Sankyo40%
mentions📖Daiwa Sangyo Co., Ltd.40%
mentions📖Dalhousie University40%
mentions📖David Wilkinson40%
mentions📖DeepMind40%
mentions📖Dennis J. Selkoe40%
mentions📖Dennis W. Dickson — Leading Neuropathologist40%
mentions📖Diaxa Group40%
mentions📖Divi's Laboratories Ltd.40%
mentions📖Dong-A ST40%
mentions📖Dr. Reddy's Laboratories40%
mentions📖Dr. Reddy's Laboratories40%
mentions📖Dr. Susan M. Catalano — O-GlcNAcylation Biomarker Expert40%
mentions📖ETH Zurich40%
mentions📖Ed Lein40%
mentions📖Eduardo Tolosa — PSP Researcher40%
mentions📖EicOsis, Inc.40%
mentions📖Eisai Co., Ltd.40%
mentions📖Erasmus MC40%
mentions📖Eric E. Schadt40%
mentions📖Eric M. Reiman40%
mentions📖Essential Genomics40%
mentions📖Eurofarma Laboratorios40%
mentions📖Evgen Pharma plc40%
mentions📖Exscientia plc40%
mentions📖Feinstein Institutes for Medical Research40%
mentions📖Forest Neurotech40%
mentions📖Francis Mahe [1]40%
mentions📖Fudan University40%
mentions📖Fujifilm Holdings Corporation40%
mentions📖Fujirebio Diagnostics40%
mentions📖GSK (GlaxoSmithKline)40%
mentions📖Gador40%
mentions📖Galapagos NV40%
mentions📖Genentech Inc.40%
mentions📖Genexine40%
mentions📖Gil D. Rabinovici40%
mentions📖Gilead Sciences40%
mentions📖Ginkgo Bioworks40%
mentions📖Giovanni B. Frisoni40%
mentions📖Giovanni Volpe40%
mentions📖Gladstone Institutes40%
mentions📖GliaCure40%
mentions📖Google Ventures (GV)40%
mentions📖Great Lakes NeuroTechnologies40%
mentions📖GreyOrange40%
mentions📖Grunenthal40%
mentions📖Guido C. Croce40%
mentions📖H. Lundbeck A/S40%
mentions📖HC Health40%
mentions📖Hanmi Pharmaceutical40%
mentions📖Harvard Medical School40%
mentions📖Harvard Medical School40%
mentions📖Harvard University40%
mentions📖Healios K.K.40%
mentions📖Health Catalyst40%
mentions📖Healx40%
mentions📖Helios Inc.40%
mentions📖Hengrui Medicine40%
mentions📖Henrik Zetterberg40%
mentions📖Hilary W. Brueck40%
mentions📖Hongkui Zeng40%
mentions📖Horizon Robotics40%
mentions📖Hospital Clínic de Barcelona40%
mentions📖Huong V. Ha40%
mentions📖Hypera Pharma40%
mentions📖IBM Watson Health40%
mentions📖INSERM40%
mentions📖INmune Bio, Inc.40%
mentions📖IQVIA40%
mentions📖IXICO Technologies40%
mentions📖Icahn School of Medicine at Mount Sinai40%
mentions📖Idorsia Pharmaceuticals Ltd.40%
mentions📖Idorsia40%
mentions📖Imperial College London40%
mentions📖Indiana University40%
mentions📖Inhibrx40%
mentions📖InnoCan Pharmaceuticals Ltd.40%
mentions📖Innovent Biologics40%
mentions📖Insitro40%
mentions📖Institutions Overview40%
mentions📖Invicro40%
mentions📖Israeli Biotechnology Companies40%
mentions📖JCR Pharmaceuticals40%
mentions📖JW Pharmaceutical40%
mentions📖Jakob P. Wiss40%
mentions📖James E. Galvin40%
mentions📖James Leverenz40%
mentions📖James M. Fair40%
mentions📖Javier R. Blazquez40%
mentions📖Jeffrey Cummings40%
mentions📖Jennifer L. Whitwell40%
mentions📖Jessica B. Langbaum40%
mentions📖Jian Zhang40%
mentions📖John H. Morrison40%
mentions📖John Hardy40%
mentions📖John O'Keefe40%
mentions📖John Q. Trojanowski40%
mentions📖John Q. Trojanowski40%
mentions📖John R. Troxel [1]40%
mentions📖Johns Hopkins University40%
mentions📖Johnson & Johnson (Janssen)40%
mentions📖Johnson & Johnson40%
mentions📖Johnson & Johnson40%
mentions📖Jorg B. Born40%
mentions📖Juan R. Marcano40%
mentions📖K Health40%
mentions📖KU Leuven40%
mentions📖Kaj Blennow40%
mentions📖Kaken Pharmaceutical Co., Ltd.40%
mentions📖Karl H. Beacher40%
mentions📖Katherine A. Ellenbogen40%
mentions📖KeifeRx40%
mentions📖Keith A. Josephs40%
mentions📖Kenneth Rockwood40%
mentions📖Kenneth S. Kosik40%
mentions📖Kinevo Inc.40%
mentions📖Kinexx Co., Ltd.40%
mentions📖King's College London40%
mentions📖Kissei Pharmaceutical Co., Ltd.40%
mentions📖Kolon Life Science40%
mentions📖Korean Dementia Association40%
mentions📖Krasue Inc.40%
mentions📖Kristine Yaffe40%
mentions📖Kyle J. Travaglini40%
mentions📖Kyorin Pharmaceutical Co., Ltd.40%
mentions📖Kyoto University40%
mentions📖Kyowa Kirin Co., Ltd.40%
mentions📖LSVT Global40%
mentions📖Larry B. Honig40%
mentions📖Lars M. B. Lancaster40%
mentions📖Laura A. Barnett40%
mentions📖Lauren Shore40%
mentions📖Lea T. Grinberg40%
mentions📖Lennart Mucke40%
mentions📖Leonard Petrucelli40%
mentions📖Lewy Body Dementia Association40%
mentions📖Lewy Body Society40%
mentions📖Li-Huei Tsai40%
mentions📖Life Biosciences40%
mentions📖Ludwig Maximilian University of Munich (LMU)40%
mentions📖Luigi A. Squillacioti40%
mentions📖Lundbeck40%
mentions📖Lupin Ltd.40%
mentions📖Lupin Pharmaceuticals40%
mentions📖MEDINFORM40%
mentions📖Manifold Bio40%
mentions📖Manu S. Sharma40%
mentions📖Mapi Pharma Ltd.40%
mentions📖Marc H. Smith40%
mentions📖Marc Hutton40%
mentions📖Marc R. Hyman40%
mentions📖Marcel P. Dorval40%
mentions📖Marco A. Pedata40%
mentions📖Marcus Raichle40%
mentions📖Maria C. Barin40%
mentions📖Mariano I. Gabitto40%
mentions📖Marie C. Janson40%
mentions📖Marilyn S. Miller40%
mentions📖Mark A. Marcus40%
mentions📖Mark P. Mattson40%
mentions📖Masahiro Kato — PSP Researcher40%
mentions📖Massachusetts General Hospital40%
mentions📖Massachusetts General Hospital40%
mentions📖Mathias Jucker40%
mentions📖Mayo Clinic Jacksonville40%
mentions📖McGill University40%
mentions📖McLean Hospital40%
mentions📖MedRhythms40%
mentions📖Medesis Pharma40%
mentions📖Medical University of Vienna40%
mentions📖Michael Hawrylycz40%
mentions📖Michael S. Wolfe40%
mentions📖Michael W. Weiner40%
mentions📖Michael Ward40%
mentions📖Michel Goedert40%
mentions📖Michele M. Vis40%
mentions📖Michelle M. Miller40%
mentions📖Miguel Calero40%
mentions📖Min Wang40%
mentions📖MindMaze40%
mentions📖Mitch A. Max40%
mentions📖MitoThera40%
mentions📖Mitsubishi Tanabe Pharma Corporation40%
mentions📖Mochida Pharmaceutical Co., Ltd.40%
mentions📖Moscow State University40%
mentions📖Motif Neurotech40%
mentions📖Motus Company40%
mentions📖Mount Sinai Hospital40%
mentions📖Muse40%
mentions📖NEOFECT40%
mentions📖NYU Langone Health40%
mentions📖Nacuity Pharmaceuticals40%
mentions📖NanoCarrier Co., Ltd.40%
mentions📖National Science Foundation40%
mentions📖National University of Singapore (NUS)40%
mentions📖Neil Scales40%
mentions📖Neil W. Buckholtz40%
mentions📖Neill R. Graff-Radford40%
mentions📖Neurable40%
mentions📖Neuralink40%
mentions📖Neuraly, Inc.40%
mentions📖Neuraly, Inc.40%
mentions📖Neurastron40%
mentions📖Neurimmune40%
mentions📖NeuroGlance Inc.40%
mentions📖NeuroMit Pharmaceuticals40%
mentions📖NeuroWiki Progress40%
mentions📖NeuroWiki Work Queue40%
mentions📖Neurolixis SAS40%
mentions📖Neurotrope BioScience40%
mentions📖NextMind40%
mentions📖NextMind40%
mentions📖Nick Fox40%
mentions📖Nicola Ray — Movement Disorder Researcher40%
mentions📖Nippon Shinyaku Co., Ltd.40%
mentions📖Nobelpharma Co., Ltd.40%
mentions📖Nodthera Ltd.40%
mentions📖Northwestern University Feinberg School of Medicine40%
mentions📖Olga G. Berg40%
mentions📖Oligomerix, Inc.40%
mentions📖Olink Proteomics40%
mentions📖Ono Pharmaceutical40%
mentions📖Onward Medical40%
mentions📖OpenBCI Inc.40%
mentions📖Optum40%
mentions📖Osaka University40%
mentions📖Otsuka Holdings Co., Ltd.40%
mentions📖Otsuka Pharmaceutical40%
mentions📖Oura40%
mentions📖PD GSK3 Inhibitor Companies40%
mentions📖PD Warrior40%
mentions📖Pablo G. Martinez40%
mentions📖Page Suggestions40%
mentions📖Pascal E. Sanchez40%
mentions📖Passage Bio40%
mentions📖Paul S. Aisen40%
mentions📖Peking University40%
mentions📖Peking University40%
mentions📖Peptidream Inc.40%
mentions📖Peter H. Davies40%
mentions📖Peter St George-Hyslop40%
mentions📖Pfizer Inc40%
mentions📖PharmaEssentia Corp40%
mentions📖Physitrack40%
mentions📖Pierluigi B. Bellan40%
mentions📖Pinteon40%
mentions📖Polyneuron Pharmaceuticals AG40%
mentions📖Priavoid GmbH40%
mentions📖Prionab40%
mentions📖ProMab40%
mentions📖Probiodrug40%
mentions📖Probiosfera40%
mentions📖Projects40%
mentions📖Prothena Corporation plc40%
mentions📖Queen Square Neurology40%
mentions📖QurAlis40%
mentions📖R. Terry Bartus40%
mentions📖RA Capital Management40%
mentions📖RIBOMIC Inc.40%
mentions📖RNP Inc.40%
mentions📖Rachel Whalley40%
mentions📖Recepta Biopharma40%
mentions📖Recursion Pharmaceuticals40%
mentions📖RedHill Biopharma Ltd.40%
mentions📖Regeneron Pharmaceuticals40%
mentions📖Regenxbio Inc.40%
mentions📖Reisa A. Sperling40%
mentions📖ReproCELL Inc.40%
mentions📖Researcher Rankings40%
mentions📖Researchers Dashboard40%
mentions📖Richard C. Mohs40%
mentions📖RightEye40%
mentions📖Robert J. Balazs40%
mentions📖Roderick MacKinnon40%
mentions📖Roemmers40%
mentions📖Ronald C. Petersen40%
mentions📖Ronald C. Peterson40%
mentions📖Rudolph E. Tanzi40%
mentions📖Ruhr University Bochum40%
mentions📖Rune Labs40%
mentions📖Rush University Medical Center40%
mentions📖Russian Academy of Sciences40%
mentions📖Russian Academy of Sciences40%
mentions📖Ruth E. Abeta40%
mentions📖Samsung Bioepis40%
mentions📖Samsung Electronics40%
mentions📖SanBio Co., Ltd.40%
mentions📖Sanja M. Joseph40%
mentions📖Sarah Chen — Clinical PSP Researcher40%
mentions📖Saval Corporation40%
mentions📖Savar40%
mentions📖Science Corp40%
mentions📖Sergei S. Skvortsov40%
mentions📖Sergio G. Casa40%
mentions📖Servier40%
mentions📖SfN Annual Meeting 202540%
mentions📖SfN Annual Meeting40%
mentions📖Shanghai Jiao Tong University40%
mentions📖Shanghai NeuroTech40%
mentions📖Shanghai Pharmaceuticals40%
mentions📖Shionogi & Co., Ltd.40%
mentions📖Simcere Pharmaceutical Co., Ltd.40%
mentions📖Simons Foundation40%
mentions📖Sinergium Biotech40%
mentions📖Sino Biopharm40%
mentions📖Sorbonne University40%
mentions📖Sosei Group Corporation40%
mentions📖Stanford University40%
mentions📖Stanford University40%
mentions📖Statistical Methods for Biomarker Combinations40%
mentions📖Stefan C. Mueller40%
mentions📖Stefan D. Djurdjevic40%
mentions📖Stefan J. Teipel40%
mentions📖Stefan Kremers40%
mentions📖Steven M. Hyman40%
mentions📖Sumitomo Pharma40%
mentions📖Sun Pharmaceutical Industries40%
mentions📖Sun Pharmaceutical Industries40%
mentions📖Supernus Pharmaceuticals40%
mentions📖Susumu Tonegawa40%
mentions📖Suzanne L. Henderson40%
mentions📖Syneos Health40%
mentions📖TCI Co., Ltd. (大江生醫)40%
mentions📖TaiGen Biotechnology40%
mentions📖TaiRx Inc40%
mentions📖TaiRx, Inc.40%
mentions📖Taiping Zhang40%
mentions📖Taisho Pharmaceutical40%
mentions📖Takeda Pharmaceutical Company40%
mentions📖Tamas Rev E. Szter40%
mentions📖TauRx Pharmaceuticals40%
mentions📖Technical University of Munich (TUM)40%
mentions📖Tetsuya Kimura40%
mentions📖Teva Pharmaceutical Industries Ltd.40%
mentions📖Thomas Arzberger40%
mentions📖Thomas J. Grabowski40%
mentions📖Tokyo NeuroInnovation40%
mentions📖Toyo Biotechnology40%
mentions📖Tree Pharmaceutical Co., Ltd.40%
mentions📖Treventis Corporation40%
mentions📖Treventis Corporation40%
mentions📖TriNetX40%
mentions📖TrueBinding40%
mentions📖Tsinghua University40%
mentions📖Tsumura & Co.40%
mentions📖Tyromotion40%
mentions📖UCB Pharma40%
mentions📖UCB40%
mentions📖Ultragenyx Pharmaceutical40%
mentions📖Universitat de Barcelona40%
mentions📖Universitat de Barcelona40%
mentions📖University College London (UCL)40%
mentions📖University College London40%
mentions📖University of Barcelona40%
mentions📖University of Belgrade40%
mentions📖University of British Columbia40%
mentions📖University of British Columbia40%
mentions📖University of California Davis40%
mentions📖University of California Irvine40%
mentions📖University of California Los Angeles40%
mentions📖University of California San Diego40%
mentions📖University of California San Francisco40%
mentions📖University of California Santa Barbara40%
mentions📖University of California, Berkeley40%
mentions📖University of California, Irvine (UCI)40%
mentions📖University of Cambridge - MRC LMB40%
mentions📖University of Cambridge40%
mentions📖University of Chicago40%
mentions📖University of Cincinnati40%
mentions📖University of Colorado Anschutz Medical Campus40%
mentions📖University of Colorado Boulder40%
mentions📖University of Edinburgh40%
mentions📖University of Erlangen-Nuremberg40%
mentions📖University of Florida40%
mentions📖University of Geneva40%
mentions📖University of Heidelberg40%
mentions📖University of Helsinki40%
mentions📖University of Illinois Urbana-Champaign40%
mentions📖University of Iowa40%
mentions📖University of Kansas40%
mentions📖University of Kentucky40%
mentions📖University of Lausanne40%
mentions📖University of Lille40%
mentions📖University of Maastricht40%
mentions📖University of Melbourne40%
mentions📖University of Miami40%
mentions📖University of Miami40%
mentions📖University of Michigan40%
mentions📖University of Michigan40%
mentions📖University of Milan40%
mentions📖University of Minnesota40%
mentions📖University of Naples Federico II40%
mentions📖University of North Carolina (UNC)40%
mentions📖University of North Carolina at Chapel Hill40%
mentions📖University of Nottingham40%
mentions📖University of Oslo40%
mentions📖University of Oxford40%
mentions📖University of Oxford40%
mentions📖University of Pennsylvania (UPenn)40%
mentions📖University of Pennsylvania40%
mentions📖University of Pittsburgh40%
mentions📖University of Rome Sapienza40%
mentions📖University of Rostock40%
mentions📖University of Rostock40%
mentions📖University of Salento40%
mentions📖University of Sao Paulo40%
mentions📖University of Sao Paulo40%
mentions📖University of Sheffield40%
mentions📖University of Southampton40%
mentions📖University of Southern California40%
mentions📖University of Strasbourg40%
mentions📖University of Sydney40%
mentions📖University of Texas Health San Antonio40%
mentions📖University of Texas Health40%
mentions📖University of Texas Medical Branch40%
mentions📖University of Texas Southwestern Medical Center40%
mentions📖University of Texas Southwestern40%
mentions📖University of Tokyo40%
mentions📖University of Toronto40%
mentions📖University of Tubingen40%
mentions📖University of Turin40%
mentions📖University of Wisconsin-Madison40%
mentions📖University of Zurich40%
mentions📖Université de Montréal40%
mentions📖Vaccinex, Inc.40%
mentions📖Vanqua Bio40%
mentions📖Vaxart40%
mentions📖Vaxxinity, Inc.40%
mentions📖Vedanta Biosciences40%
mentions📖Verily Life Sciences40%
mentions📖Vertex Pharmaceuticals40%
mentions📖Vicore Pharma40%
mentions📖Victor L. Vidal40%
mentions📖Vincere Biosciences40%
mentions📖Virginia M.-Y. Lee40%
mentions📖Walter J. Koroshetz40%
mentions📖Washington University in St. Louis40%
mentions📖Washington University in St. Louis40%
mentions📖Wave Life Sciences40%
mentions📖Weihong Song40%
mentions📖Wellcome Trust40%
mentions📖William W. Seeley40%
mentions📖Willink Pharma40%
mentions📖Wuxi Biologics40%
mentions📖Wyss Center40%
mentions📖Yongjun Liu40%
mentions📖Yoshinori Masuzoe40%
mentions📖Yuan Zhang40%
mentions📖Yuhan Corporation40%
mentions📖Z-index Pharma40%
mentions📖Zhejiang University40%
mentions📖boehringer-ingelheim40%
mentions📖can-fite-biopharma40%
mentions📖cas40%
mentions📖cu-anschutz-medical-campus40%
mentions📖cureapp-inc40%
mentions📖department-of-defense40%
mentions📖dzne40%
mentions📖emotiv40%
mentions📖feinstein-institutes-for-medical-research40%
mentions📖fitbit40%
mentions📖gladstone40%
mentions📖heqIX40%
mentions📖icometrix40%
mentions📖indiana-university-school-medicine40%
mentions📖indiana-university-school-of-medicine40%
mentions📖innosino-biopharma40%
mentions📖kallyope40%
mentions📖max-planck-society40%
mentions📖mitsubishi-tanabe-pharma40%
mentions📖monash-university40%
mentions📖nijmegen40%
mentions📖novo-nordisk40%
mentions📖rankings40%
mentions📖sapienza-university-rome40%
mentions📖scineuro-pharmaceuticals40%
mentions📖semmelweis-university40%
mentions📖sonde-health40%
mentions📖sun-yat-sen-university40%
mentions📖thomas-jefferson-university40%
mentions📖uni-cambridge40%
mentions📖uni-pittsburgh40%
mentions📖uni-washington40%
mentions📖uniQure40%
mentions📖university-michigan40%
mentions📖university-of-arizona40%
mentions📖university-of-basel40%
mentions📖university-of-bristol40%
mentions📖university-of-edinburgh40%
mentions📖university-of-lyon40%
mentions📖university-of-manchester40%
mentions📖university-of-perugia40%
mentions📖university-of-rochester40%
mentions📖university-of-utah40%
mentions📖university-of-virginia40%
mentions📖university-of-wisconsin-madison40%
mentions📖university-virginia-school-medicine40%
mentions📖uthealth-houston40%
mentions📖versant-ventures40%
mentions📖wake-forest40%
mentions📖withings40%
mentions📖yale-university40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia40%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation40%
related🧪Complement C1QA Spatial Gradient in Cortical Layers40%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation40%
related🧪APOE Isoform Expression Across Glial Subtypes40%
related🧪Noradrenergic-Tau Propagation Blockade40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics40%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪SASP-Driven Aquaporin-4 Dysregulation40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪Complement C1q Mimetic Decoy Therapy40%
related🧪Complement C1q Subtype Switching40%
related🧪Complement-Mediated Synaptic Pruning Dysregulation40%
related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A40%
related🧪Temporal Decoupling via Circadian Clock Reset40%
related🧪Circadian Clock-Autophagy Synchronization40%
related🧪Optogenetic Microglial Deactivation via Engineered Inhibitor40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Transcriptional Autophagy-Lysosome Coupling40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective40%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪HDAC3-Selective Inhibition for Clock Reset40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Axonal RNA Transport Reconstitution40%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Glycosaminoglycan Template Disruption Approach40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Lysosomal Positioning Dynamics Modulation40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Netrin-1 Gradient Restoration40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Purinergic P2Y12 Inverse Agonist Therapy40%
related🧪PARP1 Inhibition Therapy40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪Mitochondrial-Lysosomal Contact Site Engineering40%
related🧪Reelin-Mediated Cytoskeletal Stabilization Protocol40%
related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%
related🧪Selective Acid Sphingomyelinase Modulation Therapy40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪Cross-Seeding Prevention Strategy40%
related🧪Temporal TET2-Mediated Hydroxymethylation Cycling40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction40%
related🧪TFEB-PGC1α Mitochondrial-Lysosomal Decoupling40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Low Complexity Domain Cross-Linking Inhibition40%
related🧪Transglutaminase-2 Cross-Linking Inhibition Strategy40%
related🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam40%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro40%
related🧪Sleep Spindle-Synaptic Plasticity Enhancement40%
related🧪Adenosine-Astrocyte Metabolic Reset40%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro40%
related🧪Hypocretin-Neurogenesis Coupling Therapy40%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption40%
related🧪Mitochondrial RNA Granule Rescue Pathway40%
related🧪Quantum Coherence Disruption in Cellular Communication40%
related🔬What are the mechanisms underlying selective vulnerability o39%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp39%
related🔬What are the mechanisms underlying tdp-43 phase separation t39%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub